{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:14:38Z","timestamp":1792142078073,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004881","name":"Mexican Social Security Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Secretaria de Ciencia Humanidades Tecnologia e Innovacion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.neuroscience.2026.06.011","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T01:00:29Z","timestamp":1781312429000},"page":"198-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Recent advances in neurodegenerative diseases therapeutics: The inhibition of monoacylglycerol lipase strategy"],"prefix":"10.1016","volume":"610","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7739-110X","authenticated-orcid":false,"given":"Delia Maciel","family":"Mendoza-Camacho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7975-6825","authenticated-orcid":false,"given":"Hugo Alejandro","family":"Espinoza-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Viveros-Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Eduardo","family":"Flores-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0220-5523","authenticated-orcid":false,"given":"Aldo Rafael","family":"Tejeda-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.neuroscience.2026.06.011_b0005","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1080\/14740338.2017.1388371","article-title":"Drugs approved for the treatment of multiple sclerosis: review of their safety profile","volume":"16","author":"Auricchio","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.06.011_b0010","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s12035-015-9213-3","article-title":"Neuroprotective effect of JZL184 in MPP+-treated SH-SY5Y cells through CB2 receptors","volume":"53","author":"Aymerich","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.011_b0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/glia.22742","article-title":"Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo","volume":"63","author":"Bernal-Chico","year":"2015","journal-title":"Glia"},{"issue":"12","key":"10.1016\/j.neuroscience.2026.06.011_b0020","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem. Biol."},{"issue":"10291","key":"10.1016\/j.neuroscience.2026.06.011_b0025","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet (London, England)."},{"issue":"30","key":"10.1016\/j.neuroscience.2026.06.011_b0030","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1523\/JNEUROSCI.0037-23.2023","article-title":"Monoacylglycerol lipase protects the presynaptic cannabinoid 1 receptor from desensitization by endocannabinoids after persistent inflammation","volume":"43","author":"Bouchet","year":"2023","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.06.011_b0035","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1021\/acs.jmedchem.5b01812","article-title":"Development and pharmacological characterization of selective blockers of 2-arachidonoyl glycerol degradation with efficacy in rodent models of multiple sclerosis and pain","volume":"59","author":"Brindisi","year":"2016","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.011_b0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.06.011_b0045","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/ejn.14982","article-title":"The neuropharmacology of cannabinoid receptor ligands in central signaling pathways","volume":"55","author":"Brunt","year":"2022","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.011_b0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-3-319-57193-5_8","article-title":"Multiple sclerosis: basic and clinical","volume":"15","author":"Buzzard","year":"2017","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.neuroscience.2026.06.011_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108394","article-title":"Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases","volume":"244","author":"Chen","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.011_b0060","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0048-16.2016","article-title":"Neuronal and astrocytic monoacylglycerol lipase limit the spread of endocannabinoid signaling in the cerebellum","volume":"3","author":"Chen","year":"2016","journal-title":"Eneuro"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.06.011_b0065","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.celrep.2012.09.030","article-title":"Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease","volume":"2","author":"Chen","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuroscience.2026.06.011_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1684885","article-title":"Levodopa-induced dyskinesia in Parkinson's disease: an updated review of pharmacological treatments","volume":"17","author":"Chen","year":"2025","journal-title":"Front. Aging Neurosci."},{"issue":"20","key":"10.1016\/j.neuroscience.2026.06.011_b0075","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1021\/acs.jmedchem.8b00951","article-title":"Identification of ABX-1431, a selective inhibitor of monoacylglycerol lipase and clinical candidate for treatment of neurological disorders","volume":"61","author":"Cisar","year":"2018","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.011_b0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer's disease: experimental models and reality","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.06.011_b0085","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16400","article-title":"Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis","volume":"31","author":"Dubbioso","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuroscience.2026.06.011_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2014.05.021","article-title":"The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model","volume":"35","author":"Fern\u00e1ndez-Su\u00e1rez","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuroscience.2026.06.011_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2014.12.003","article-title":"Identification of CB receptors in human nigral neurons that degenerate in Parkinson's disease","volume":"587","author":"Garc\u00eda","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.011_b0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.011_b0105","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12964-025-02418-2","article-title":"Relevance of a peripheral site of action outside the brain-blood barrier for the beneficial effects of CB(2) receptor activation in experimental ALS in male mice","volume":"23","author":"G\u00f3mez-Almer\u00eda","year":"2025","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.neuroscience.2026.06.011_b0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pnpbp.2015.03.017","article-title":"Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease","volume":"64","author":"G\u00f3mez-G\u00e1lvez","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.06.011_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109940","article-title":"Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis","volume":"252","author":"Guadalupi","year":"2024","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neuroscience.2026.06.011_b0120","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1007\/s12035-021-02400-2","article-title":"Inhibition of 2-arachidonoylglycerol metabolism alleviates neuropathology and improves cognitive function in a tau mouse model of Alzheimer's disease","volume":"58","author":"Hashem","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"50","key":"10.1016\/j.neuroscience.2026.06.011_b0125","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1002\/anie.201407807","article-title":"A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis","volume":"53","author":"Hern\u00e1ndez-Torres","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.neuroscience.2026.06.011_b0130","doi-asserted-by":"crossref","unstructured":"Hu, S.S.-J., Mackie, K., 2015. Distribution of the endocannabinoid system in the central nervous system. In: Pertwee RG, editor. Endocannabinoids. Cham: Springer International Publishing. p. 59-93.","DOI":"10.1007\/978-3-319-20825-1_3"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.06.011_b0135","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1212\/CON.0000000000001345","article-title":"Amyotrophic lateral sclerosis and other motor neuron diseases","volume":"29","author":"Izenberg","year":"2023","journal-title":"Continuum (Minneapolis, Minn)."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.011_b0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-017-1788-5","article-title":"Parkinson's disease: experimental models and reality","volume":"135","author":"Jiang","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.06.011_b0145","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.3390\/ijms25074050","article-title":"Potential therapeutic targets to modulate the endocannabinoid system in Alzheimer\u2019s disease","volume":"25","author":"Kanwal","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.06.011_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268590","article-title":"A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature","volume":"17","author":"Kemble","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.011_b0155","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.nbd.2010.10.023","article-title":"Reactive astrocytes and Wnt\/\u03b2-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease","volume":"41","author":"L'Episcopo","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.06.011_b0160","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.25380","article-title":"The endocannabinoid system in Alzheimer's disease: a network meta-analysis","volume":"102","author":"Liu","year":"2024","journal-title":"J. Neurosci. Res."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.06.011_b0165","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.chembiol.2009.05.009","article-title":"Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism","volume":"16","author":"Long","year":"2009","journal-title":"Chem. Biol."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.011_b0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.31887\/DCNS.2020.22.3\/blutz","article-title":"Neurobiology of cannabinoid receptor signaling","volume":"22","author":"Lutz","year":"2020","journal-title":"Dial. Clin. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.011_b0175","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fnmol.2017.00166","article-title":"Metabolism of the endocannabinoid anandamide: open questions after 25 Years","volume":"10","author":"Maccarrone","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.011_b0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/glia.24280","article-title":"Endocannabinoid signaling in the central nervous system","volume":"71","author":"Martinez Ramirez","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2026.06.011_b0185","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbi.2019.06.036","article-title":"Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2","volume":"81","author":"Mart\u00ednez-Torres","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuroscience.2026.06.011_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2025.12.025","article-title":"Monoacylglycerol lipase inhibition improves motor function and reduces oxidative stress in hemiparkinsonian mice","volume":"594","author":"Mendoza-Camacho","year":"2026","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.011_b0195","doi-asserted-by":"crossref","first-page":"e1583","DOI":"10.1002\/wsbm.1583","article-title":"Neurodegeneration in multiple sclerosis","volume":"15","author":"Mey","year":"2023","journal-title":"WIREs Mech. Dis."},{"key":"10.1016\/j.neuroscience.2026.06.011_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105717","article-title":"Binding of the monoacylglycerol lipase (MAGL) radiotracer [3H]T-401 in the rat brain after status epilepticus","volume":"175","author":"Mikkelsen","year":"2024","journal-title":"Neurochem. Int."},{"issue":"23","key":"10.1016\/j.neuroscience.2026.06.011_b0205","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1093\/hmg\/ddx348","article-title":"Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels","volume":"26","author":"Moller","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"13","key":"10.1016\/j.neuroscience.2026.06.011_b0210","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.3390\/ijms25137183","article-title":"A comprehensive approach to Parkinson\u2019s disease: addressing its molecular, clinical, and therapeutic aspects","volume":"25","author":"Muleiro Alvarez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.06.011_b0215","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/mds.28681","article-title":"Monoacylglycerol lipase inhibition in tourette syndrome: a 12-week, randomized, controlled study","volume":"36","author":"M\u00fcller-Vahl","year":"2021","journal-title":"Movem. Dis.: Off. J. Movem. Disorder Soc."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.06.011_b0220","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/bph.12411","article-title":"Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS","volume":"171","author":"Murataeva","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.06.011_b0225","series-title":"The Endocannabinoid System: Genetics, Biochemistry, Brain Disorders, and Therapy","author":"Murillo-Rodriguez","year":"2017"},{"issue":"8","key":"10.1016\/j.neuroscience.2026.06.011_b0230","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ddr.21461","article-title":"Dose translation between laboratory animals and human in preclinical and clinical phases of drug development","volume":"79","author":"Nair","year":"2018","journal-title":"Drug Dev. Res."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.011_b0235","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13311-018-0603-x","article-title":"Cannabinoid CB1 and CB2 receptors, and monoacylglycerol lipase gene expression alterations in the basal ganglia of patients with Parkinson\u2019s disease","volume":"15","author":"Navarrete","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.011_b0240","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13311-018-0603-x","article-title":"Cannabinoid CB1 and CB2 receptors, and monoacylglycerol lipase gene expression alterations in the basal ganglia of patients with Parkinson's disease","volume":"15","author":"Navarrete","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.06.011_b0245","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/cn400116z","article-title":"Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors","volume":"4","author":"Niphakis","year":"2013","journal-title":"ACS Chem. Nerosci."},{"issue":"6057","key":"10.1016\/j.neuroscience.2026.06.011_b0250","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation","volume":"334","author":"Nomura","year":"2011","journal-title":"Science (New York, N.Y.)"},{"issue":"38","key":"10.1016\/j.neuroscience.2026.06.011_b0255","doi-asserted-by":"crossref","first-page":"13420","DOI":"10.1523\/JNEUROSCI.2075-11.2011","article-title":"Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice","volume":"31","author":"Pan","year":"2011","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.06.011_b0260","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s12640-023-00661-4","article-title":"Monoacylglycerol lipase inhibition prevents short-term mitochondrial dysfunction and oxidative damage in rat brain synaptosomal\/mitochondrial fractions and cortical slices: role of cannabinoid receptors","volume":"41","author":"Paredes-Ruiz","year":"2023","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuroscience.2026.06.011_b0265","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neuropharm.2017.03.037","article-title":"Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS","volume":"124","author":"Pasquarelli","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2026.06.011_b0270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuint.2017.08.003","article-title":"Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson's disease","volume":"110","author":"Pasquarelli","year":"2017","journal-title":"Neurochem. Int."},{"issue":"22","key":"10.1016\/j.neuroscience.2026.06.011_b0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213954","article-title":"Alzheimer's disease: treatment strategies and their limitations","volume":"23","author":"Passeri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.06.011_b0280","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.celrep.2012.05.001","article-title":"A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease","volume":"1","author":"Piro","year":"2012","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.06.011_b0285","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.celrep.2012.05.001","article-title":"A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease","volume":"1","author":"Piro Justin","year":"2012","journal-title":"Cell Rep."},{"issue":"14","key":"10.1016\/j.neuroscience.2026.06.011_b0290","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.3390\/ijms22147319","article-title":"New insights into multiple sclerosis mechanisms: lipids on the track to control inflammation and neurodegeneration","volume":"22","author":"Podbielska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.06.011_b0295","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neurol.2019.08.012","article-title":"What are the infectious risks with disease-modifying drugs for multiple sclerosis and how to reduce them? a review of literature","volume":"176","author":"Pourcher","year":"2020","journal-title":"Revue Neurol."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.011_b0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020353","article-title":"Mitochondrial and redox disturbances in multiple sclerosis","volume":"18","author":"Rajda","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.neuroscience.2026.06.011_b0305","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/nn.3168","article-title":"Animal models of multiple sclerosis: the good, the bad and the bottom line","volume":"15","author":"Ransohoff","year":"2012","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.011_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/ph16020148","article-title":"System: chemical characteristics and biological activity","volume":"16","author":"Rezende","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.011_b0315","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1748-1716.2011.02280.x","article-title":"The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors","volume":"204","author":"Savinainen","year":"2012","journal-title":"Acta Physiol (Oxf.)"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.011_b0320","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41401-018-0075-x","article-title":"Brain activity of anandamide: a rewarding bliss?","volume":"40","author":"Scherma","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.06.011_b0325","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.06.011_b0330","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021639","article-title":"Synapse dysfunctions in multiple sclerosis","volume":"24","author":"Schwarz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.neuroscience.2026.06.011_b0335","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262211132","article-title":"The endocannabinoid system in human disease: molecular signaling, receptor pharmacology, and therapeutic innovation","volume":"26","author":"Serban","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.011_b0340","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bcpt.13595","article-title":"Targeting 2-arachidonoylglycerol signalling in the neurobiology and treatment of depression","volume":"129","author":"Silveira","year":"2021","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.011_b0345","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s12264-023-01034-9","article-title":"Glia connect inflammation and neurodegeneration in multiple sclerosis","volume":"39","author":"Sun","year":"2023","journal-title":"Neurosci. Bull."},{"issue":"17","key":"10.1016\/j.neuroscience.2026.06.011_b0350","doi-asserted-by":"crossref","first-page":"9588","DOI":"10.3390\/ijms25179588","article-title":"Glial cells as key regulators in neuroinflammatory mechanisms associated with multiple sclerosis","volume":"25","author":"Theophanous","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.06.011_b0355","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson's disease","volume":"20","author":"Vijiaratnam","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuroscience.2026.06.011_b0360","article-title":"Roles of the cannabinoid system in the basal ganglia in Parkinson\u2019s disease","volume":"16\u20132022","author":"Wang","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.06.011_b0365","article-title":"Components of the endocannabinoid system and effects of cannabinoids against bone diseases: a mini-review","volume":"12","author":"Xin","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.06.011_b0370","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12888-025-06661-2","article-title":"Global mortality, prevalence and disability-adjusted life years of Alzheimer's disease and other dementias in adults aged 60 years or older, and the impact of the COVID-19 pandemic: a comprehensive analysis for the global burden of disease 2021","volume":"25","author":"Yu","year":"2025","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.06.011_b0375","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26185668","article-title":"Targeting monoacylglycerol lipase in pursuit of therapies for neurological and neurodegenerative diseases","volume":"26","author":"Zanfirescu","year":"2021","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"11","key":"10.1016\/j.neuroscience.2026.06.011_b0380","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112979","article-title":"Endocannabinoid metabolism and traumatic brain injury","volume":"10","author":"Zhu","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.06.011_b0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120416","article-title":"Hyperphosphorylation of intrinsically disordered tau protein induces an amyloidogenic shift in its conformational ensemble","volume":"10","author":"Zhu","year":"2015","journal-title":"PLoS One"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226003866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226003866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:17:36Z","timestamp":1784132256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226003866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":77,"alternative-id":["S0306452226003866"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.06.011","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in neurodegenerative diseases therapeutics: The inhibition of monoacylglycerol lipase strategy","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}